Advanced therapeutic strategies for HBV-related acute-on-chronic liver failure

Background Acute-on-chronic liver failure (ACLF) is increasingly recognized as a distinct clinical entity and is associated with a high short-term mortality. The most common cause of ACLF is chronic hepatitis B worldwide. Currently, there is no standardized approach for the management of ACLF and th...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Hepatobiliary & pancreatic diseases international 2015-08, Vol.14 (4), p.354-360
Hauptverfasser:	Liu, Xin-Yu, Peng, Feng, Pan, Ya-Jie, Chen, Jun
Format:	Artikel
Sprache:	eng
Schlagworte:	acute-on-chronic liver failure Acute-On-Chronic Liver Failure - diagnosis Acute-On-Chronic Liver Failure - mortality Acute-On-Chronic Liver Failure - therapy Acute-On-Chronic Liver Failure - virology Antiviral Agents - adverse effects Antiviral Agents - therapeutic use chronic hepatitis B Combined Modality Therapy Endocrinology & Metabolism Gastroenterology and Hepatology Hepatitis B, Chronic - complications Hepatitis B, Chronic - diagnosis Hepatitis B, Chronic - mortality Hepatitis B, Chronic - therapy Humans Immunotherapy - adverse effects Immunotherapy - methods Liver Transplantation - adverse effects Liver, Artificial - adverse effects Risk Factors Stem Cell Transplantation - adverse effects therapy Time Factors Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!